Kimberly-Clark (KMB) Q1 2026 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 (Q&A) earnings summary
28 Apr, 2026Executive summary
Net sales for Q1 2026 were $4.2 billion, up 2.7% year-over-year, with organic sales growth of 2.5% driven by strong volume, innovation, and productivity, despite macroeconomic uncertainty.
Adjusted operating profit grew 3.7% year-over-year to $732 million, with broad-based volume gains and stable global market share.
Income from continuing operations increased 22.1% to $574 million; diluted EPS from continuing operations was $1.70, up 22.3%.
Company reaffirmed its 2026 outlook, highlighting upcoming product launches and the pending Kenvue acquisition and IFP joint venture, with regulatory and operational readiness advancing.
Continued execution of transformation and innovation strategies, with significant charges and insurance recoveries impacting results.
Financial highlights
Gross margin was 36.8%, with adjusted gross margin at 37.9%, down 60 bps year-over-year.
Adjusted EPS from continuing operations was $1.60, down 1.2% year-over-year; adjusted EPS attributable to the company was $1.97, up 2.1%.
Cash provided by operations was $745 million, more than double the prior year, driven by insurance recovery and improved working capital.
Capital spending increased to $424 million, with full-year guidance at $1.3 billion.
Total debt was $7.1 billion as of March 31, 2026.
Outlook and guidance
2026 organic sales growth expected to match or exceed category averages (~2.5%), with mid- to high-single-digit constant-currency adjusted operating profit growth and double-digit adjusted EPS growth from continuing operations.
Adjusted free cash flow projected at ~$2B, with capital expenditures accelerating to ~$1.3B.
Currency translation expected to favorably impact EPS by ~170 bps.
Management expects continued input cost pressures due to geopolitical conflicts and energy price volatility.
Transformation Initiative expected to deliver $3.0 billion in gross productivity savings and $200 million in SG&A savings by end of 2026.
Latest events from Kimberly-Clark
- Strategic shift to health and wellness, strong growth, and disciplined integration drive transformation.KMB
Barclays 18th Annual Americas Select Conference5 May 2026 - Q1 2026 delivered 2.7% sales growth and strong profit, with transformation and acquisitions progressing.KMB
Q1 2026 Prepared Remarks28 Apr 2026 - Innovation and acquisitions drive growth, margin expansion, and strong EPS outlook.KMB
Q4 2025 Prepared Remarks11 Apr 2026 - Board recommends director elections, auditor ratification, say-on-pay, and opposes independent chair proposal.KMB
Proxy filing23 Mar 2026 - Shareholders will vote on directors, executive pay, and auditor ratification at the annual meeting.KMB
Proxy filing23 Mar 2026 - Transformation, innovation, and Kenvue integration drive global growth and value creation.KMB
Consumer Analyst Group of New York Conference (CAGNY) 202619 Feb 2026 - Issuance of common stock for a merger was approved; final results to be filed with the SEC.KMB
AGM 20263 Feb 2026 - Q2 profit and EPS surged on organic growth, innovation, and raised full-year outlook.KMB
Q2 2024 Prepared Remarks3 Feb 2026 - Q2 organic sales up 5% and adjusted EPS up 19%-20%, with 2024 outlook raised.KMB
Q2 2024 (Q&A)3 Feb 2026